Syapse aims to provide hospitals with actionable oncology insights through its point-of-care precision medicine software platform. The platform organizes and presents structured clinical and genomic data to match patients with targeted therapies based on treatment and outcome information from patients across the U.S.
The Series D round comprised funding from returning investors Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Safeguard Scientifics and Social Capital. New investors included Amgen Ventures, Medidata Solutions, Merck Global Health Innovation Fund and Roche Venture Fund.
More articles on data analytics & precision medicine:
NIH taps 14 medical societies, community groups to recruit ‘All of Us’ participants
Study: 5 health indicators predict cardiovascular risk
Researchers analyze DNA from ‘supercentenarians’ aged 110+ to discover secret to longevity
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.